Yossi Maimon Insider Trading
Get free email notifications about insider trading for Yossi Maimon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yossi Maimon. Yossi Maimon is a VP, Chief Financial Officer in Protalix BioTherapeutics, Inc. ($PLX).
Address: C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455 CARMIEL 20100Israel
Companies in which Yossi Maimon is an Insider
Protalix BioTherapeutics, Inc.
Trading Symbol: PLXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yossi Maimon: VP, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 08 2010
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Yossi Maimon
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 77,769 | 75,591 | 75,964 | |
Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Payment of Exercise | F | 9.73 | 7,769 | 75,592 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 77,769 | 75,591 | 0 | -77,769 to 0 (-100.00 %) |
Oct 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 9.67 | 70,000 | 676,900 | 0 | 70 K to 0 (-100.00 %) |
Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | M | 0.97 | 70,000 | 68,040 | 153,733 | |
Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Buy | M | 0.97 | 70,000 | 68,040 | 0 | -70,000 to 0 (-100.00 %) |
Sep 08 2010 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Sell | S | 8.16 | 31,500 | 257,040 | 0 | 31.5 K to 0 (-100.00 %) |